Pancreatic carcinoma;Das pankreaskarzinom

Internist

Volumn 41, Issue 9, 2000, Pages 848-859

  Sternheim, E T ^a   Voigt, J ^a   Kaspar, W ^a   Dippold, W G ^a  

^a St Vinzenz und Elizabeth Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GEMCITABINE; PROTEIN P16; PROTEIN P53; RAS PROTEIN;

AGE DISTRIBUTION; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER INHIBITION; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RISK; DIFFERENTIAL DIAGNOSIS; DNA REPAIR; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HISTOLOGY; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CARCINOMA; PROGNOSIS; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; NEOPLASM STAGING; PALLIATIVE CARE; PANCREATIC NEOPLASMS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033826778     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050637     Document Type: Review

References (68)

1. Chemotherapy for pancreatic carcinoma
2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
3. Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults
4. Phase 1B study of concurrent administration of marimastat and gemcitabine in non-resectable pancreatic cancer
5. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer
6. Pitfalls in the interpretation of MR cholangiopancreatography
7. Mortality in relation to smoking. 40 years' observations on male British doctors
8. Aktualisierte interdisziplinare leitlinien der deutschen krebsgesellschaft e.V. zur therapie des exokrinen pankreaskarzinoms
9. Invasion and metastasis in pancreatic cancer
10. Diabetes mellitus as a risk factor for pancreatic cancer
11. Occupation and pancreatic cancer risk in Louisiana
12. Blind evaluation of endoscopic retrograde cholangiopancreatography (ERCP) in the diagnosis of pancreatic carcinoma: The double duct and other signs
13. Computed tomography in the diagnosis and staging of cholangiocarcinoma and pancreatic carcinoma
14. Kombinierter Einsatz von MRT, MRCP und kontrast-verstarkter 2-Phasen 3D-MRA in der Diagnostik von Pankreastumoren:erste klinische Ergebnisse
15. Progress in cancer genetics: Lessons from pancreatic cancer
16. Epidemiology of and risk factors for pancreatic cancer
17. Prospective evaluation of pain in exocrine pancreatic cancer
18. Role of EUS in the preoperative staging of pancreatic cancer: A large single-center experience
19. Diabetes and the risk of pancreatic cancer
20. Italian Pancreatic Cancer Study Group. Diabetes and the risk of pancreatic cancer
21. Neue molekularbiologische erkenntnisse aus der pankreaskarzinom-forschung
22. FDG-PET evaluation of indeterminate pancreatic masses
23. Cigarette smoking and cancer of the pancreas: Evidence from a population-based-control-study in Toronto Canada
24. Pathology of incipient pancreatic cancer
25. Total pancreatectomy for cancer of the pancreas: Is it appropriate?
26. Mucin-producing pancreatic tumors: Comparison of MR cholangiopancreatography with endoscopic retrograde cholangiopancreatography
27. Symptoms of pancreatic cancer
28. Experimental drugs and drug combinations in pancreatic cancer
29. Fats in seasoning and the relationship to pancreatic cancer
30. Role of tumor markers, cytogenetics
31. Descriptive epidemiology of pancreatic cancer in Japan
32. Pancreatitis and the risk of pancreatic cancer. International pancreatitis study group
33. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group
34. Therapy of locally unresectable pancreatic carcinoma: A randomised comparison of high dose (600 rads) radiation alone, moderate dose radiation (4000 fads + 5-fluorouracil) and high dose radiation + 5-fluorouracil
35. Lymphatic and local spread of T1 and T2 pancreatic cancer. A study of autopsy material
36. ESPAC-1 interim results: A European randomised study to asses the roles of adjuvant chemotherapy (5-FU + Folinic Acid) and adjuvant chemoradiation (40 Gy + 5-FU) in respectable pancreatic cancer
37. EUS and K-ras analysis of pure pancreatic juice collected via a duodenoscope after secretin stimulation for diagnosis of pancreatic mass lesion: A prospective study
38. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography an CT scan
39. Estimates of the worldwide incidence of 25 major cancers in 1990
40. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group
41. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes
42. Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy
43. Experience with staging laparascopy in pancreatic malignancy
44. Pankreastumoren
45. Retinoids in pancreatic cancer
46. Staging of pancreatic cancer: Analysis of literature results
47. Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas
48. De novo expression of intercellular Adhesion Molecule 1 (ICAM-1, CD54) in pancreas cancer
49. Alcohol and pancreatic cancer in blacks and whites in the United States
50. Dietary and nutritional factors and pancreatic cancer: A case control study based on direct interviews
51. Imaging and staging of biliopancreatic malignancy: Role of ultrasound
52. Randomized trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice
53. Vegetables, fruit and cancer. II. Mechanisms
54. Karzinom des exokrinen pankreas
55. Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis
56. Intraductal papillary tumors of the pancreas: Evaluation with endoscopic ultrasonography
57. Occurrence of non-gastric cancer in the digestive tract after remote partial gastrectomy: Analysis of an Amsterdam cohort
58. Detection of micrometastasis in bone marrow of pancreatic cancer patients
59. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality
60. Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases
61. Remote partial gastrectomy as a risk factor for pancreatic cancer: Potential for preventive strategies
62. Impact of non-invasive imaging techniques on the trend of pancreatic cancer mortality in Austria
63. Standard surgical treatment in pancreatic cancer
64. Surgical palliation for pancreatic cancer: Developments during the past two decades
65. Occurrence, trends and environment etiology of pancreatic cancer
66. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
67. Six hundred fifty consecutive pancreaticoduo-denectomies in the 1990s: Pathology, complications, and outcomes
68. FDG-positron emission tomography in pancreatic cancer